Status:

COMPLETED

Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI

Lead Sponsor:

Shandong University

Conditions:

Esophageal Neoplasms

Artificial Intelligence

Eligibility:

All Genders

18-80 years

Brief Summary

Detection and differentiation of esophageal squamous neoplasia (ESN) are of value in improving patient outcomes. Probe-based confocal laser endomicroscopy (pCLE) can diagnose ESN accurately.However th...

Eligibility Criteria

Inclusion

  • aged between 18 and 80;
  • agree to give written informed consent;

Exclusion

  • advanced esophageal squamous cell carcinoma or esophageal stenosis;
  • having no suspicious lesion of ESN found by WLE and IEE
  • known allergy to fluorescein sodium;
  • having coagulopathy or impaired renal function;
  • being pregnant or breastfeeding.

Key Trial Info

Start Date :

August 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2023

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT04136236

Start Date

August 1 2019

End Date

January 31 2023

Last Update

November 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Qilu Hospital, Shandong University

Jinan, Shandong, China, 250001